Duluth vs J.Jill
DLTH and JILL side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DLTH and JILL compare
J.Jill is the larger company, worth 2.1 times as much as Duluth ($356M against $167M).
On earnings, J.Jill is cheaper: it trades at 13.4× trailing earnings, against 31.4× for Duluth.
J.Jill grew revenue faster over the last twelve months (−2.2% versus −8.6% for Duluth).
J.Jill keeps more of each dollar of sales as profit, with a net margin of 4.6% compared with 1.1% at Duluth.
J.Jill pays a dividend yielding 1.5%; Duluth does not pay one.
J.Jill scores higher on the StockData Score (13 against 8 for Duluth), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DLTH | JILL |
|---|---|---|
| Size and price | ||
| Market cap | $167M | $356M |
| Share price | $4.39 | $23.96 |
| Change, 1 year | 47.8% | 55.6% |
| Change, 5 years | −73.6% | 22.4% |
| Beta (5Y) | 0.70 | 0.93 |
| Employees | 89 | 3,140 |
| StockData Score | ||
| Total score | 8 | 13 (better) |
| Valuation score | 3 (better) | 2 |
| Growth score | 2 (better) | 1 |
| Performance score | 2 | 4 (better) |
| Health score | 1 | 3 (better) |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | 31.4× | 13.4× (better) |
| P/S | 0.3× (better) | 0.6× |
| P/B | 0.9× (better) | 2.5× |
| EV/EBITDA | 4.2× (better) | 5.1× |
| P/FCF | 2.9× (better) | 7.3× |
| FCF yield | 34.5% (better) | 13.7% |
| Fair value | $4.57 | $26.18 |
| Margin of safety | 3.9% | 8.5% (better) |
| Growth | ||
| Revenue growth (TTM) | −8.6% | −2.2% (better) |
| Revenue growth, 5Y average | −2.4% | 6.9% (better) |
| Net income growth (TTM) | – | −26.2% |
| EPS growth (TTM) | – | −25.1% |
| Profitability | ||
| Gross margin | 58.3% | 70.0% (better) |
| Operating margin | 1.7% | 8.1% (better) |
| Net margin | 1.1% | 4.6% (better) |
| FCF margin | 10.4% (better) | 8.3% |
| Return on equity | 3.4% | 20.8% (better) |
| Return on invested capital | 4.7% | 31.8% (better) |
| Financial health | ||
| Debt / equity | – | 0.52 |
| Net debt / EBITDA | – | −0.06 |
| Interest coverage | 2.5× | 5.5× (better) |
| Current ratio | 1.88 (better) | 1.30 |
| Altman Z-score | 2.44 (better) | 2.13 |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | – | 1.5% |
| Payout ratio | – | 18.8% |
| Years of dividend growth | – | 1 |
| Buyback yield | – | 2.3% |
| Shareholder yield | 0.00% | 3.8% (better) |
| Ownership | ||
| Held by institutions | 15.3% | 50.2% |
| Held by insiders | 43.7% | 7.5% |
| Insider net buying, 12 months | $62.5K (better) | −$1.6M |
| Short interest, % of float | 1.4% | 6.7% |
Go deeper
- DLTH stock overview
- DLTH income statement
- DLTH valuation and score
- JILL stock overview
- JILL income statement
- JILL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.